Trending...
- Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo Soldiers
- Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
- "Regenerating Life": documentary film challenges current assumptions about climate change
Cardiovascular Imaging Expert to Lead Core Lab Services in Support of Clinical Trials
BOSTON - PRDelivery -- As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
More on PR Delivery
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
More on PR Delivery
- Wave2 Launches New Dynamic Data Integration Features to Elevate Bank and Credit Union Convenience
- Texas Advocacy Project Aids 10k+ Abuse Victims Annually; Offers Subject Matter Experts for Domestic Violence Awareness Month
- Higi Selects ThoroughCare to Assist in Managing Chronically Ill Patients
- Introducing Stack & Sprout: The Revolutionary Vertical Plant Growing System for Urban Gardeners
- Introducing the State-of-the-Art National Security Operations Center: Enhancing Safety and Vigilance Nationwide
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Contact
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Source: Cardiovascular Clinical Sciences
0 Comments
Latest on PR Delivery
- RelyMD Bolsters its Telehealth Platform with Mental Health Services via CuraLinc Partnership
- Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo Soldiers
- AMERICAST Provides PreCast Pads to Charge Stations
- Sheila Stubbs Taylor of Detroit music royalty is "Chasing" on new single
- Sidow Sobrino Announces 12th Album, "Seminal"
- Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
- Maryland Sedation Dentistry and Surgical Center Opens in Frederick Maryland
- LokiBots is one of the 35 early-stage Generative AI startups selected for AWS ML Elevate program 2023 cohort
- Mil-Spec Safety & Security Launches New Website
- Trinity Prairie Real Estate Lists Mesmerizing 16.78-Acre Estate in Colleyville, Texas
- Rhody Rug Revolutionizes Online Shopping Experience with the Launch of their New Direct-to-Consumer Website
- Long Island businessman turned recording artist, John Beyer, to release his first love song aptly titled, …"Love You More"
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Exploring the World of Web3? Lympid Puts Users Front and Center
- "Regenerating Life": documentary film challenges current assumptions about climate change
- Flint's Got Talent Returns To Showcase Creativity In Community
- Autonomous eVTOLs $25 Billion Market by 2030
- Global Life Settlement Exchange: Selling a Life Insurance Policy Might be a Better Option Than Letting it Lapse or Surrendering it
- Jiritsu Raises $10.2 Million in Funding to Revolutionize Verifiable Compute
- Heartland Soccer Set to Host Sold Out Midwest All Boys Tournament this Weekend